Drug Shortage Report for RECOMBIVAX HB

Last updated on 2022-06-23 History
Report ID 873
Drug Identification Number 02243676
Brand name RECOMBIVAX HB -(PRESERVATIVE FREE)
Common or Proper name (hepatitis B vaccine [recombinant])
Company Name MERCK CANADA INC
Market Status MARKETED
Active Ingredient(s) HEPATITIS B SURFACE ANTIGEN
Strength(s) 10MCG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR
Packaging size 10MCG/1ML 10X1DOSE VIAL
ATC code J07BC
ATC description VIRAL VACCINES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2017-08-01
Actual start date 2017-08-04
Estimated end date 2022-06-30
Actual end date 2022-06-22
Shortage status Resolved
Updated date 2022-06-23
Company comments Format 1DOSE VIAL remains available. / Le format 1DOSE VIAL est encore disponible.
Health Canada comments
Tier 3 Status No
Contact Address 16750 ROUTE TRANSCANADIENNE
KIRKLAND, QUEBEC
CANADA H9H 4M7
Company contact information 1-800-567-2594 medinfocanada@merck.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2017-03-13 English Compare
v2 2017-03-13 French Compare
v3 2017-03-13 French Compare
v4 2017-03-13 French Compare
v5 2017-03-23 English Compare
v6 2017-03-23 English Compare
v7 2017-04-10 French Compare
v8 2017-04-10 English Compare
v9 2017-04-10 English Compare
v10 2017-04-10 French Compare
v11 2017-05-10 English Compare
v12 2017-05-10 French Compare
v13 2017-05-11 English Compare
v14 2017-05-11 English Compare
v15 2017-05-11 French Compare
v16 2017-06-19 English Compare
v17 2017-08-02 English Compare
v18 2017-08-02 English Compare
v19 2017-08-06 English Compare
v20 2017-08-06 English Compare

Showing 1 to 20 of 43